FDA approves Roche drug for chronic leukemia based on research that it slows ... - Wa

[INCIID News Feed]

Drug Discovery & Development
<img alt="" height="1" width="1" />
FDA approves Roche drug for chronic leukemia based on research that it slows ...
Washington Post
WASHINGTON — The Food and Drug Administration has approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow. The agency cleared Gazyva to fight chronic lymphocytic leukemia in combination with ...
Roche, Biogen snag FDA nod for &#39;breakthrough&#39; Rituxan successorFierceBiotech
FDA approves Roche leukemia drug GazyvaReuters
Roche Wins US Approval for First Breakthrough Therapy Drug (1)Businessweek
Healio -Wall Street Journal
all 15 news articles &raquo;


More...